Calspan Awarded DARPA Air Combat Evolution (ACE) Contract
July 08, 2020 10:04 ET | Calspan
Buffalo, New York, July 08, 2020 (GLOBE NEWSWIRE) -- Calspan Corporation has been awarded a $14.1M, four-year contract by the Defense Advanced Research Projects Agency (DARPA) to develop full-scale...
logo-aviatrix.jpg
Aviatrix Unveils CoPilot for Enterprise-Class Operational Visibility of Multi-Cloud Networks
April 21, 2020 09:02 ET | Aviatrix
SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) -- Aviatrix, the cloud network platform, today announced CoPilot to provide enterprises with advanced operational visibility and troubleshooting...
logo-aviatrix.jpg
Autonomous Technology Industry Leader, EasyMile, Standardizes Global Cloud Infrastructure Using Aviatrix Cloud Networking Software
February 26, 2020 09:00 ET | Aviatrix
SANTA CLARA, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Aviatrix, the leading provider of cloud networking software for the multi-cloud enterprise, today announced that EasyMile, a global leader in...
Banner graphic
Aviatrix Announces ALTITUDE 2020 – Above the Clouds™ Multi-Cloud Networking Industry Event
February 25, 2020 09:02 ET | Aviatrix
March 3rd Event in Santa Clara Hosted by theCUBE and Also Livestreamed Best Practices and Real-World Experiences from IT Execs and Systems Integrators Architecting Networks that Rise Above AWS,...
Nearmap logo.jpg
Nearmap Brings Precise Roof Geometry Measurement to Your Fingertips Through API Integration
February 04, 2020 09:00 ET | Nearmap
DALLAS, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Nearmap, a company that delivers high-resolution aerial imagery as a service to businesses across the world, announced today the coming of a new roof...
DiaMedica-Logo.png
DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
August 13, 2019 16:35 ET | DiaMedica Therapeutics Inc.
Phase Ib study of DM199 in Chronic Kidney Disease enrollment completeEncouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II...
DiaMedica-Logo.png
DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019
August 12, 2019 08:00 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that Rick Pauls, President and CEO, will be presenting at the 2019 Intellisight Conference,...
DiaMedica-Logo.png
DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019
August 08, 2019 16:00 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its second quarter 2019 financial results will be released after the markets close on...
DiaMedica-Logo.png
DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting
April 30, 2019 16:58 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, April 30, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that Dr Harry Alcorn, its Chief Medical Officer...
DiaMedica-Logo.png
DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
February 14, 2019 08:00 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, Feb. 14, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that it has initiated dosing patients with chronic...